Product Catalog

42-1475

Molybdenum › Molybdenum(VI) oxide (99.998%-Mo) PURATREM

Physical Characteristics: melting point 795°C, boiling point subl., density 4.69

Please log in or choose your country below to view prices.

Buy 5 - 9 of an item and get a 5% discount.
Buy 10 or more of an item and get a 10% discount.

SECTION 1: Product Identification
Chemical Name:	Molybdenum (VI) oxide (99.998%-Mo) PURATREM
Product Number:	42-1475
CAS Registry Number:	1313-27-5
Formula:	MoO3
EINECS Number:	215-204-7
Chemical Family:	metal oxide
Synonym:	Molybdic anhydride

SECTION 2: Composition and Information on Ingredients
Ingredient	CAS Number	Percent	ACGIH (TWA)	OSHA (PEL)
Title Compound	1313-27-5	100	10mg/m3 (as Mo-	15mg/m3

SECTION 3: Hazards Identification
Emergency Overview:	Irritating to skin, eyes and respiratory tract. Danger of serious damage to health by prolonged exposure through inhalation and if swallowed.
Primary Routes of Exposure:	Ingestion, inhalation
Eye Contact:	Causes slight to mild irritation of the eyes.
Skin Contact:	Causes slight to mild irritation of the skin.
Inhalation:	Irritating to the nose, mucous membranes and respiratory tract. Danger of serious damage to health by inhalation.
Ingestion:	Danger of serious damage to health by ingestion. Ingestion may lead to vomiting and diarrhea.
Acute Health Effects:	Irritating to skin, eyes and respiratory tract. Danger of serious damage to health by prolonged exposure through inhalation and if swallowed.
Chronic Health Effects:	No information available on long-term chronic effects.
NTP:	No
IARC:	No
OSHA:	No

SECTION 4: First Aid Measures
Eye Exposure:	Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention.
Skin Exposure:	Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists.
Inhalation:	Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Ingestion:	Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel.

SECTION 5: Fire Fighting Measures
Flash Point:	not applicable
Autoignition Temperature:	none
Explosion Limits:	none
Extinguishing Medium:	not applicable
Special Fire Fighting Procedures:	Non-flammable. No special fire fighting procedures.
Hazardous Combustion and Decomposion Products:	No hazardous combustion or decomposition products.
Unusual Fire or Explosion Hazards:	No unusual fire or explosion hazards.

SECTION 6: Accidental Release Measures
Spill and Leak Procedures:	Small spills can be mixed with vermiculite or sodium carbonate and swept up.

SECTION 7: Handling and Storage
Handling and Storage:	Store in a tightly sealed container.

SECTION 8: Exposure Controls and Personal Protection
Eye Protection:	Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection:	Wear protective clothing and gloves.
Ventilation:	Material may form a fine dust. If possible, handle the material in an efficient fume hood.
Respirator:	If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134.
Additional Protection:	No additional protection required.

SECTION 9: Physical and Chemical Properties
Color and Form:	pale green pwdr.
Molecular Weight:	143.95
Melting Point:	795°C
Boiling Point:	subl.
Vapor Pressure:	no data
Specific Gravity:	4.69
Odor:	none
Solubility in Water:	insoluble

SECTION 10: Stability and Reactivity
Stability:	air and moisture stable
Hazardous Polymerization:	no hazardous polymerization
Conditions to Avoid:	none
Incompatibility:	none
Decomposition Products:	none

SECTION 11: Toxicological Information
RTECS Data:	Inhalation (human-man); TCLo: 6 mg/m3/4Y. Oral (rodent); LD50: 2689 mg/kg. Inhalation (rat); LD50: >5840 mg/m3/4H. Administration onto the skin (rat); LD50: >2 gm/kg. Intraperitoneal (mouse); LD50: 141 mg/kg. Subcutaneous (mouse); LD50: 94 mg/kg. Intraperitoneal (guinea pig); LD75: 400 mg/kg. Inhalation (rat); TCLo: 10 mg/m3/2H/9W-I. Inhalation (rat); TCLo: 100 mg/m3/6H/14D-I. Inhalation (mouse); TCLo: 300 mg/m3/6H/14D-I. Inhalation (rat); TCLo: 100 mg/m3/6H/2Y-I. Inhalation (mouse); TCLo: 10 mg/m3/6H/2Y-I. Intraperitoneal (mouse); TDLo: 4750 mg/kg/7W-I. Hamster embryo; Micronucleus test: 500 mg/L.
Carcinogenic Effects:	No data available
Mutagenic Effects:	No data available
Tetratogenic Effects:	No data available

SECTION 12: Ecological Information
Ecological Information:	No information available

SECTION 13: Disposal Considerations
Disposal:	Dispose of according to local, state and federal regulations.

SECTION 14: Transportation
Shipping Name (CFR):	Non-hazardous
Hazard Class (CFR):	NA
Additional Hazard Class (CFR):	NA
Packaging Group (CFR):	NA
UN ID Number (CFR):	NA
Shipping Name (IATA):	Non-hazardous
Hazard Class (IATA):	NA
Additional Hazard Class (IATA):	NA
Packaging Group (IATA):	NA
UN ID Number (IATA):	NA

SECTION 15: Regulatory Information
TSCA:	Listed in the TSCA inventory.
SARA (Title 313):	Not reportable under SARA Title 313.
Second Ingredient:	none
Third Ingredient:	none

SECTION 16: Other Information
Disclaimer:	The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information.
Preparation Date:	8/07/2000
Revision Date:	5/02/2006